Furthermore, custom synthesized CK1δ inhibitors were able to reduce TDP-43 phosphorylation and protect cultured cells against ethacrynic acid challenge, which induces neuroblastoma cell death by mediating the phosphorylation of TDP-43 [27]. The gene discussed is TARDBP; the disease is neuroblastoma.